AMA: Trump administration requiring pricing information in TV drug ads

| 2 Min Read

Statement attributable to:

Barbara L. McAneny, MD 

President, American Medical Association

“The Trump Administration has taken a step in the right direction by requiring pricing information in direct-to-consumer television advertising of prescription drugs. Last year, the AMA called for regulations requiring the ads to include the manufacturer’s list price of those drugs, and we have supported similar legislative efforts. This small dose of transparency will help patients have a more complete picture when faced with prescription drug ads. 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Folding rulers in shape of a stock curve

Is your physician well-being strategy working? 9 things to know

| 16 Min Read
Figure sits on a stack of books alongside health data

This doctor shares why physicians can make great entrepreneurs

| 7 Min Read
Military veteran speaking with another individual

Accelerated PTSD care offers faster relief for veterans

| 7 Min Read
David Purow, MD, featured on "Health vs. Hype" AMA podcast

5 things patients should know about detoxing

| 5 Min Read